161 related articles for article (PubMed ID: 3680212)
1. The impact of delayed fibrinopeptide-A release on fibrin structure. Studies of an abnormal fibrinogen.
Carr ME; Qureshi GD
J Biol Chem; 1987 Nov; 262(32):15568-74. PubMed ID: 3680212
[TBL] [Abstract][Full Text] [Related]
2. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
[TBL] [Abstract][Full Text] [Related]
3. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod.
Shen LL; Hermans J; McDonagh J; McDonagh RP
Am J Physiol; 1977 Jun; 232(6):H629-33. PubMed ID: 879301
[TBL] [Abstract][Full Text] [Related]
4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
5. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
7. [Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release].
Soya K; Takezawa Y; Terasawa F; Okumura N
Rinsho Byori; 2012 Jun; 60(6):499-505. PubMed ID: 22880226
[TBL] [Abstract][Full Text] [Related]
8. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
Suontaka AM; Blombäck M; Chapman J
Transfusion; 2003 May; 43(5):568-75. PubMed ID: 12702176
[TBL] [Abstract][Full Text] [Related]
9. Acquired coagulation inhibitor delaying fibrinopeptide release.
Marciniak E; Greenwood MF
Blood; 1979 Jan; 53(1):81-92. PubMed ID: 758215
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
[TBL] [Abstract][Full Text] [Related]
11. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
12. Analysis of reptilase and thrombin-induced changes in fibrinogen subunits by isoelectric focussing.
Exner T; Rickard KA; Kronenberg H
Thromb Res; 1983 Aug; 31(3):489-97. PubMed ID: 20218004
[TBL] [Abstract][Full Text] [Related]
13. Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization.
Moen JL; Gorkun OV; Weisel JW; Lord ST
Blood; 2003 Oct; 102(7):2466-71. PubMed ID: 12805063
[TBL] [Abstract][Full Text] [Related]
14. The release of small amounts of fibrinopeptide-B (FPB) is of critical importance for the thrombin clotting time.
Holm B; Kierulf P; Godal HC
Thromb Res; 1986 May; 42(4):517-26. PubMed ID: 3715815
[TBL] [Abstract][Full Text] [Related]
15. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
[TBL] [Abstract][Full Text] [Related]
17. Influence of Ca2+ on the structure of reptilase-derived and thrombin-derived fibrin gels.
Carr ME; Gabriel DA; McDonagh J
Biochem J; 1986 Nov; 239(3):513-6. PubMed ID: 3548699
[TBL] [Abstract][Full Text] [Related]
18. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
Okude M; Yamanaka A; Morimoto Y; Akihama S
Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyethyl starch on the structure of thrombin- and reptilase-induced fibrin gels.
Carr ME
J Lab Clin Med; 1986 Dec; 108(6):556-61. PubMed ID: 2431085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
